OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Mergers & Acquisitions
Mergers & Acquisitions Summary
Each week, Viridian publishes insights and analysis on completed M&A transactions in the prior week. Our analysis includes:
-
- M&A Market Commentary
- Public and Private Companies
- Buyers & Sellers
- YTD M&A Analysis
- M&A by Industry Sector
- Deal Structure and Valuation Analysis
- Pending Deal Risk Arb Analysis
- Valuation Gap Analysis
Quick Links
Transaction Activities
Week ended 03/17/2023
- One M&A transaction closed this week for $13M compared to six transactions for $19.66M in the prior year.
YTD Activities
- Twenty-nine transactions totaling $741.81M have closed YTD, compared to fifty-six transactions for $2,031.16M last year.
- The 2023 YTD average transaction size of $260M is the lowest in recent years.
Pending Risk Deal Arb Analysis
-
- The Cresco/Columbia deal spread narrowed by 1040bp to 65.2% on 3/17/23. Still, a 65.2% arb spread screams skepticism that the agreement will survive as presently structured. An unannualized rate of return of over 65% for a four-month investment seems too good to be true. If you think this deal will close, as does one noted sell-side analyst we respect, then why wouldn’t you try to establish the arb position of being long Columbia and short Cresco?
Valuation Gap Analysis
- The valuation gap narrowed to 1.74 on 3/17/23 and remained close to the lowest measure since we began tracking this measure. The valuation gap is the difference between the EV/NTM EBITDA multiple for the largest MSOs and the multiple for the less than $300M market cap group, which are their primary targets.
- This measure has been a significant driver of M&A activity since a larger gap creates an opportunity for more accretive transactions. The gap tends to increase in improving markets while declining in retreating markets to the greater trading liquidity of the larger companies. We believe the current gap is understated by the massive illiquidity of cannabis stocks which may not be accurate indicators of the prices at which the entire companies would trade.
Please login to your account to view data charts.
